Brief: MoonLake Immunotherapeutics Q3 EPS USD -0.93
Wed 12:01
BRIEF-MoonLake Immunotherapeutics Q3 EPS USD -0.93 Nov 04 (Reuters) - MoonLake Immunotherapeutics Q3 net income USD -79.545 million.
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake Immunotherapeutics reports results for the quarter ended September 30 - Earnings Summary
Switzerland's MoonLake Q3 net loss widens as R&D costs rise
Brief: MoonLake Immunotherapeutics Q3 EPS USD -0.93
MoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed